Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Sequential vs Bismuth Quadruple Therapy for H. pylori
NCT03148366Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Feb 2015; status: completed.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03148366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148366.